Yesterday saw the release of the paper published in the New England Journal of Medicine containing the hotly awaited data concerning the HIV vaccine trial that took place in Thailand. There was already some discussion of the initial results, which were reported in September and discussed by Colin and Martin. As has already been discussed, there is a very cautious consensus due to the statistical analysis of the trial only *just* falling on the side of significant.







